Ranitidine - Causes Of Zantac Recall, Overview
12/30/2020
The Zantac recall involves both over-the-counter and prescription Zantac products. The recalled product, the Zantac Punch, was manufactured by Zantac Pharmaceuticals. The recall is a part of the pharmaceutical company's efforts to respond to recent new safety issues regarding the composition and strength of Zantac, particularly its main ingredient, methylene blue (MBC). Methylene blue is used in Zantac to help reduce eye inflammation and pain caused by dryness and inflammation of the eye. Check out these info sources for pharma recals now.
Ranitidine is also manufactured by Zantac. A number of Ranitidine deaths were reported in 2020, when patients started using this drug without proper supervision and at higher doses. Ranitidine is not the only Zantac product that has been linked to adverse side effects, including heartburn and peptic ulcers. There are no known safe levels of Ranitidine in either pregnant or non-pregnant women.
Ranitidine is also manufactured by Zantac. A number of Ranitidine deaths were reported in 2020, when patients started using this drug without proper supervision and at higher doses. Ranitidine is not the only Zantac product that has been linked to adverse side effects, including heartburn and peptic ulcers. There are no known safe levels of Ranitidine in either pregnant or non-pregnant women.